UHPLC-MS/MS standardized extract of Vernonia amygdalinaleaf inhibits CYP2C9 and CYP3A4 activities in hepatic cells of control and streptozotocin-induced diabetic rats

MLA

Sabbagh, Bassel Al., et al. “UHPLC-MS/MS Standardized Extract of Vernonia Amygdalinaleaf Inhibits CYP2C9 and CYP3A4 Activities in Hepatic Cells of Control and Streptozotocin-Induced Diabetic Rats.” Drug Metabolism and Personalized Therapy, vol. 39, no. 4, Jan. 2025, pp. 231–41. EBSCOhost, https://doi.org/10.1515/dmpt-2024-0005.

APA

Sabbagh, B. A., Palanirajan, V. K., Chew, Y.-L., Chin, J. H., Ahmad, M., & Akowuah, G. A. (2025). UHPLC-MS/MS standardized extract of Vernonia amygdalinaleaf inhibits CYP2C9 and CYP3A4 activities in hepatic cells of control and streptozotocin-induced diabetic rats. Drug Metabolism and Personalized Therapy, 39(4), 231–241. https://doi.org/10.1515/dmpt-2024-0005

Chicago

Sabbagh, Bassel Al., Vijayaraj Kumar Palanirajan, Yik-Ling Chew, Jin Han Chin, Mariam Ahmad, and Gabriel Akyirem Akowuah. 2025. “UHPLC-MS/MS Standardized Extract of Vernonia Amygdalinaleaf Inhibits CYP2C9 and CYP3A4 Activities in Hepatic Cells of Control and Streptozotocin-Induced Diabetic Rats.” Drug Metabolism and Personalized Therapy 39 (4): 231–41. doi:10.1515/dmpt-2024-0005.